Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients

NARecruitingINTERVENTIONAL
Enrollment

1,556

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

November 30, 2029

Study Completion Date

December 31, 2030

Conditions
Carotid Artery Diseases
Interventions
DRUG

Patients who are scheduled to undergo carotid artery stenting

"* Arm A : Single antiplatelet therapy (SAPT) with aspirin or clopidogrel~ \- 1 month of dual antiplatelet therapy(100mg aspirin q.d. and 75mg clopidogrel q.d.)→ Randomization → 11 months of single antiplatelet therapy (100mg aspirin q.d. or 75mg clopidogrel q.d.)~* Arm B : Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel - 1 month of dual antiplatelet therapy(100mg aspirin q.d. and 75mg clopidogrel q.d.) → Randomization → 11 months of dual antiplatelet therapy (100mg aspirin q.d. and 75mg clopidogrel q.d.)"

Trial Locations (1)

06351

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Woo-Keun Seo

OTHER